The delivery was shipped from the company’s Danish facility. Additionally, the shipment also follows another recent shipment of 30kg of high-THC flower delivered by the Danish Facility to Demecan in February. Based on the minimum annual quantities to be purchased by Ilios Sante during the 2-year term, the agreement has a value of about $2.3 million, with about 80% of the minimum quantities falling in the second year. Little Green Pharma reports with the signing of commercial terms back in July 2022, the shipment represents the culmination of a 9-month engagement process that includes obtaining licences, vendor qualification, quality assurance audit, and finalising quality arrangements between the parties. Ilios Sante is a wholly owned subsidiary of the Bloomwell Group, a leading European medical cannabis healthcare group.